Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
11.92
+0.06 (+0.51%)
Streaming Delayed Price
Updated: 11:27 AM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,148,157
Open
11.92
Bid (Size)
11.91 (3)
Ask (Size)
11.92 (2)
Prev. Close
11.86
Today's Range
11.74 - 12.14
52wk Range
3.210 - 18.33
Shares Outstanding
279,307,043
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
April 21, 2024
Catalysts lie ahead for both of these companies.
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
April 19, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
+47.16%
+47.16%
1 Month
-17.96%
-17.96%
3 Month
+53.21%
+53.21%
6 Month
+202.54%
+202.54%
1 Year
+109.12%
+109.12%
More News
Read More
Is Iovance Biotherapeutics Stock a Buy Now?
April 17, 2024
Via
The Motley Fool
The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
April 09, 2024
Via
MarketBeat
Topics
Cannabis
Exposures
Cannabis
Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics
March 13, 2024
Via
Benzinga
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
March 01, 2024
Via
Benzinga
Spotlight on Iovance Biotherapeutics: Analyzing the Surge in Options Activity
February 29, 2024
Via
Benzinga
Iovance Biotherapeutics: Q4 Earnings Insights
February 28, 2024
Via
Benzinga
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
April 05, 2024
Via
The Motley Fool
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
March 26, 2024
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
March 22, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
Via
InvestorPlace
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
March 18, 2024
Via
The Motley Fool
Piper Sandler Maintains Overweight Rating for Iovance Biotherapeutics: Here's What You Need To Know
March 14, 2024
Via
Benzinga
Truist Securities Maintains Buy Rating for Iovance Biotherapeutics: Here's What You Need To Know
March 07, 2024
Via
Benzinga
1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17?
March 07, 2024
Via
The Motley Fool
Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst
March 06, 2024
Via
The Motley Fool
Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
March 04, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Could Iovance Biotherapeutics Stock Help You Become a Millionaire?
March 02, 2024
Via
The Motley Fool
Iovance Biotherapeutics to Present at Upcoming Conferences
March 01, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Why Iovance Biotherapeutics Stock Got Trounced on Thursday
February 29, 2024
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?
February 29, 2024
Via
The Motley Fool
Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
February 28, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.